Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients
Article in International Journal of Molecular Sciences (December 2023)
The most recent citing publications are shown below. View all 40 publications that cite this research output on Dimensions.
The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management
Article in Cancers (November 2023)
Refinement and validation of a comprehensive clinical diagnostic model (GAMAD) based on gender, age, multitarget circulating tumour DNA methylation signature and commonly used serological biomarkers for early detection of hepatocellular carcinoma: a multicentre, prospective observational study protocol
Article in BMJ Open (September 2023)